BioVie Inc.

BIVI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
DEF 14A Sep 28, 2026 DEF 14A
8-K Sep 14, 2026 CURRENT REPORT
424B5 Sep 14, 2026 424B5
SCHEDULE 13G Sep 3, 2026
4 Aug 28, 2026
4 Aug 28, 2026
4 Aug 28, 2026
4 Aug 28, 2026
SCHEDULE 13G Aug 19, 2026
S-1/A Aug 14, 2026 FORM S-1 AMENDMENT NO.3
10-K Aug 13, 2026 FORM 10-K FOR PERIOD ENDED JUNE 30, 2026
SCHEDULE 13G/A Aug 7, 2026
SCHEDULE 13G Aug 7, 2026
FWP Aug 7, 2026 FREE WRITING PROSPECTUS
FWP Aug 6, 2026 FREE WRITING PROSPECTUS
FWP Aug 6, 2026 FREE WRITING PROSPECTUS
S-1/A Aug 6, 2026 FORM S-1 AMENDMENT NO. 2
8-K Aug 6, 2026 CURRENT REPORT
S-1/A Jul 31, 2026 FORM S-1 AMENDMENT NO. 1
S-1 Jul 17, 2026 FORM S-1 REGISTRATION STATEMENT
EFFECT Jun 29, 2026
S-3 Jun 18, 2026 FORM S-3 REGISTRATION STATEMENT
DRS Jun 11, 2026
10-Q May 11, 2026 FORM 10-Q FOR PERIOD ENDING MARCH 31, 2026
SCHEDULE 13D Mar 25, 2026
← Newer Page 1 of 21 · 504 filings Older →